Literature DB >> 30037646

Murine models of melanoma.

Jasmine Saleh1.   

Abstract

Melanoma is an aggressive and highly metastatic skin cancer, carrying a poor prognosis with a median survival time of 5.3-10 months depending on the stage of disease. Research has advanced our understanding of the underlying pathology of melanoma and strategies to prevent and treat melanoma. Mouse models have been developed to elucidate the molecular, immunological, and cellular mechanisms contributing to proliferation and metastasis of melanoma. This review article aims to provide an overview of various types of murine melanoma models, including xenograft and syngeneic transplantation models, genetically modified models, ultraviolent radiation models, and chemically induced models, and discuss the advantages and limitations of each model.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Melanoma; Metastatic; Mouse; Murine melanoma models; Skin cancer

Mesh:

Year:  2018        PMID: 30037646     DOI: 10.1016/j.prp.2018.07.008

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  5 in total

1.  A Clonogenic Assay to Quantify Melanoma Micrometastases in Pulmonary Tissue.

Authors:  Fabrizio Mattei; Sara Andreone; Giovanna Schiavoni
Journal:  Methods Mol Biol       Date:  2021

Review 2.  The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval.

Authors:  Mariana Matias; Jacinta O Pinho; Maria João Penetra; Gonçalo Campos; Catarina Pinto Reis; Maria Manuela Gaspar
Journal:  Cells       Date:  2021-11-09       Impact factor: 6.600

3.  MicroRNA-127 Inhibits the Progression of Melanoma by Downregulating Delta-Like Homologue 1.

Authors:  Ping Tian; Ling Tao; Yujun Wang; Xiaobing Han
Journal:  Biomed Res Int       Date:  2020-01-18       Impact factor: 3.411

Review 4.  Melanoma-Bearing Libechov Minipig (MeLiM): The Unique Swine Model of Hereditary Metastatic Melanoma.

Authors:  Vratislav Horak; Anna Palanova; Jana Cizkova; Veronika Miltrova; Petr Vodicka; Helena Kupcova Skalnikova
Journal:  Genes (Basel)       Date:  2019-11-09       Impact factor: 4.096

Review 5.  Cannabinoids and their derivatives in struggle against melanoma.

Authors:  Paweł Marzęda; Małgorzata Drozd; Paula Wróblewska-Łuczka; Jarogniew J Łuszczki
Journal:  Pharmacol Rep       Date:  2021-07-15       Impact factor: 3.024

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.